06:11 EST Belite Bio (BLTE) sees FY25 adjusted EPS ($1.15) vs. ($89c) last year
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLTE:
- Is BLTE a Buy, Before Earnings?
- Belite Bio price target raised to $223 from $194 at Mizuho
- Belite Bio Completes Global Enrollment in DRAGON II Tinlarebant Trial for Stargardt Disease
- Belite Bio completes enrollment in DRAGON II trial of tinlarebant
- Netflix, Meta upgraded: Wall Street’s top analyst calls